ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,672,000 | -40.6% | 370,000 | 0.0% | 2.70% | -26.5% |
| Q2 2018 | $9,550,000 | +8.1% | 370,000 | 0.0% | 3.67% | +6.4% |
| Q1 2018 | $8,832,000 | -17.2% | 370,000 | +17.5% | 3.44% | -8.4% |
| Q4 2017 | $10,669,000 | +29.3% | 315,000 | -19.2% | 3.76% | +17.1% |
| Q3 2017 | $8,252,000 | +155.0% | 390,000 | +110.5% | 3.21% | +161.1% |
| Q2 2017 | $3,236,000 | 0.0% | 185,234 | 0.0% | 1.23% | -0.7% |
| Q1 2017 | $3,236,000 | +3.4% | 185,234 | 0.0% | 1.24% | -12.1% |
| Q4 2016 | $3,130,000 | – | 185,234 | – | 1.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |